Investigation of surgical treatment for angle closure glaucoma
Trial outline
Surgical trial investigating efficacy and safety of a treatment for angle closure glaucoma.
Trial specifics
Study is still being conducted at 2 metropolitan Melbourne clinics (one city based and one suburban based)
The trial has been running for over 2 years with each participant undergoing 12 months of follow up after surgical treatment
Zave involvement
ZAVE has coordinated the study from study start up, starting with one site and adding the second site half way through the trial.
Trial achievements
For the initial site – from initial contact to first patient screened was only 3 months with time from HREC approval to First patient first visit (FPFV) only 2 weeks.
The initial study site has been the highest recruiter for this global trial with the second site well on target to meet recruitment targets despite COVID19 restrictions and halts to elective surgery in Vic.
Due to success at first site, ZAVE was approached to coordinate for a second site and for that site the recruitment targets were exceeded.
Viral arthralgia new treatment development
Trial outline
Pilot Study comparing the efficacy and safety of a new treatment (via abdominal subcutaneous injection) vs placebo injection to treat a form of viral arthralgia.
Trial specifics
The study was conducted over a 18 month period at a regional Victorian clinic. Zave were able to run the study in regional Vic, where patients often don’t get the opportunity to participate in many trials.
Zave involvement
ZAVE was involved in firstly identifying a suitable clinic in regional Victoria to collaborate on the trial. The clinic was then set up and their staff trained to work on the trial as they hadn’t conducted trials before at this clinic.
ZAVE spearheaded a participant recruitment campaign which involved sending media releases and assisting in the development of the ensuing articles in many local/regional newspapers.
Trial achievements
ZAVE coordinated the study at this site from study start up to close out with full activation and screening of patient within 3 months.
Second highest recruiter of this Australian based study.
Eye drop development for dry eye syndrome
Trial outline
Comparison of a new eye drop to treat Dry Eye syndrome against a drop currently available on the market.
Trial specifics
18 month trial with each participant undergoing three months of treatment and follow up.
Based in a busy suburban clinic with participants attending from across the eastern suburbs of Melbourne.
Zave involvement
ZAVE coordinated this study from study start-up to close out and was instrumental in the recruitment of patients into the trial, scheduling of patient appointments, conduct of clinical assessments and management of data.
Trial achievements
The site was the highest recruiter of participants in this global trial.
We have found Zave Clinical to be an excellent service provider. They play a pivotal role in our clinical studies, providing the necessary on the ground study support for many of our private clinic sites. It is no coincidence that those sites are also the best recruiters in our studies. Could not recommend them highly enough”
Russell Tait, CEO – Polyactiva Pty Ltd (Sponsor)